4//SEC Filing
Eisenstadt Richard I 4
Accession 0001104659-23-009353
CIK 0001326190other
Filed
Jan 31, 7:00 PM ET
Accepted
Feb 1, 5:31 PM ET
Size
8.4 KB
Accession
0001104659-23-009353
Insider Transaction Report
Form 4
Eisenstadt Richard I
Chief Financial Officer
Transactions
- Award
Stock Options (option to buy)
2023-01-30+105,000→ 105,000 totalExercise: $12.88Exp: 2033-01-30→ Common Stock, par value $0.0001 (105,000 underlying) - Award
Restricted Stock Units
2023-01-30+37,100→ 37,100 total→ Common Stock, par value $0.0001 (37,100 underlying)
Footnotes (3)
- [F1]Twenty-five percent of the shares underlying the option become vested and exercisable on January 30, 2024 and the remaining 75% of the shares underlying the option become vested and exercisable in substantially equal monthly installments over the 36 months following January 30, 2024, subject to the reporting person's continued service through the applicable vesting date.
- [F2]Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of Common Stock, par value $0.0001, when vested.
- [F3]The RSUs become vested in substantially equal annual installments over the 4 years following January 30, 2023, subject to the reporting person's continued service through the applicable vesting date, and have no expiration date.
Documents
Issuer
Altimmune, Inc.
CIK 0001326190
Entity typeother
Related Parties
1- filerCIK 0001515806
Filing Metadata
- Form type
- 4
- Filed
- Jan 31, 7:00 PM ET
- Accepted
- Feb 1, 5:31 PM ET
- Size
- 8.4 KB